Research progress on radiation safety guidance for thyroid cancer patients treated with 131I
10.3760/cma.j.cn115682-20220311-01123
- VernacularTitle:131I治疗甲状腺癌患者辐射安全指导的研究进展
- Author:
Bingzi SHI
1
;
Suyun YANG
Author Information
1. 山西医科大学护理学院，太原 030001
- Keywords:
Review;
Radiation safety;
Radioactive iodine therapy;
131I;
Differentiated thyroid cancer
- From:
Chinese Journal of Modern Nursing
2022;28(25):3508-3512
- CountryChina
- Language:Chinese
-
Abstract:
Radioactive iodine therapy is a safe and effective postoperative treatment for patients with differentiated thyroid cancer. Since 131I is a radionuclide, the patient becomes a living radioactive source after receiving 131I treatment, causing radioactive damage to the surrounding population and the environment. This article reviews the necessity of radiation safety guidance for differentiated thyroid cancer patients undergoing 131I treatment and the content of radiation safety guidance during hospitalization and after discharge, aiming to provide reasonable guidance on radiation safety for these patients. It provides a reference for the formulation of radiation safety management plans in line with national conditions in the future.
